Emma Walmsley, GSK CEO
January 18, 2024 03:03 PM EST
Pharma

GSK sells par­tial stake of con­sumer health spin­off Ha­le­on for $1.2B

Nicole DeFeudis

Editor

GSK is sell­ing off more of its stake in con­sumer health spin­off Ha­le­on for about $1.2 bil­lion, ac­cord­ing to a se­cu­ri­ties fil­ing.

The phar­ma gi­ant …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times